Status:
COMPLETED
In Vitro Detection of Tissue Abnormality
Lead Sponsor:
LS BioPath
Conditions:
Breast Cancer Female
Eligibility:
FEMALE
25-80 years
Phase:
NA
Brief Summary
Intraoperative ex-vivo use of the ClearEdge Imaging Device in Breast Conserving Surgery to image the excised tissue surgical margins. The study is designed to demonstrate reduction in the need for rep...
Detailed Description
Intraoperative real-time margin assessment of breast conserving surgeries can reduce the need for repeat operations due to cancer involved margins. Repeat operations result in excessive removal of ben...
Eligibility Criteria
Inclusion
- Patients aged 25-80 who are scheduled for surgical excision of tissue.
Exclusion
- No prior history of surgery at location of current surgery.
Key Trial Info
Start Date :
October 15 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 9 2012
Estimated Enrollment :
121 Patients enrolled
Trial Details
Trial ID
NCT01209182
Start Date
October 15 2010
End Date
January 9 2012
Last Update
October 3 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Mary's
San Francisco, California, United States, 94117